Suchergebnisse - "Lu, Xiaofan"

PubPharm (140)

51

Integrated Multi-Omics Data Reveals the Molecular Subtypes of Prostate Cancer

enthalten in: bioRxiv.org | 2021

von Meng, J. | Lu, X. | Jin, C. | +7

52

Immune response drives outcomes in prostate cancer : implications for immunotherapy

enthalten in: Molecular oncology | 2021

von Meng, J. | Zhou, Y. | Lu, X. | +7

53

Development and validation of a clinically applicable deep learning strategy (HONORS) for pulmonary nodule classification at CT : A retrospective multicentre study

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2021

von Lv, W. | Wang, Y. | Zhou, C. | +22

54

Cigarette smoking and all-cause mortality in rural Chinese male adults : 15-year follow-up of the Anqing cohort study

enthalten in: BMC public health | 2021

von Ye, L. | Yang, J. | Li, J. | +18

55

Cigarette smoking and all-cause mortality in rural Chinese male adults: 15-year follow-up of the Anqing cohort study

enthalten in: BMC public health | 2021

von Ye, L. | Yang, J. | Li, J. | +18

56

MOVICS : an R package for multi-omics integration and visualization in cancer subtyping

enthalten in: Bioinformatics (Oxford, England) | 2021

von Lu, X. | Meng, J. | Zhou, Y. | +2

57

Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy

enthalten in: Molecular therapy oncolytics | 2021

von Meng, J. | Lu, X. | Zhou, Y. | +7

58

Relationship between alcohol consumption and cancer in rural Chinese adults: 1 5- year follow-up cohort study

enthalten in: ResearchSquare.com | 2021

von Zhang, Y. | Li, J. | Cheng, N. | +18

59

Tumour microenvironment-based molecular profiling reveals ideal candidates for high-grade serous ovarian cancer immunotherapy

enthalten in: Cell proliferation | 2021

von Lu, X. | Ji, C. | Jiang, L. | +7

60

Liver injury after antiviral treatment of critically ill patients with COVID-19 : a single-centered retrospective cohort study

enthalten in: Annals of palliative medicine | 2021

von Ruan, X. | Lu, X. | Wang, K. | +6